<DOC>
	<DOCNO>NCT00135330</DOCNO>
	<brief_summary>This protocol design evaluate metabolic effect add exenatide , rosiglitazone , exist regimen metformin subject inadequate glycemic control .</brief_summary>
	<brief_title>An Evaluation Exenatide Rosiglitazone Subjects With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Rosiglitazone</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>HbA1c 6.8 % 10.0 % , inclusive . Body mass index ( BMI ) 25 kg/m^2 40 kg/m^2 , inclusive . Have participate study previously , receive exenatide , pramlintide acetate , GLP1 analog , dipeptidyl peptidaseIV ( DPPIV ) inhibitor Have participate interventional , medical , surgical , pharmaceutical study ( study experimental , drug , medical , surgical treatment give ) within 30 day study start . This criterion include drug receive regulatory approval indication time study start . Treated following medication : Thiazolidinedione within 5 month screen ; Sulfonylurea within 3 month screen ; Metformin/sulfonylurea combination therapy within 3 month screen ; Alphaglucosidase inhibitor within 3 month screen ; Meglitinide within 3 month screen ; Insulin 1 week within 3 month prior screen . Symlin ( pramlintide acetate ) injection Byetta ( exenatide ) injection time Chronic ( 2 week ) recent ( within 4 week study start ) use drug directly affect gastrointestinal motility Are receive chronic ( lasting longer 2 week ) systemic glucocorticoid therapy ( exclude topical inhale preparation ) receive therapy within 4 week immediately precede study start Regular use medication addictive potential opiate , narcotic , tranquilizer Systemic antineoplastic agent Systemic transplantation medication Drugs weight loss , include overthecounter medication , within 4 month prior study start</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>diabetes</keyword>
	<keyword>exenatide</keyword>
	<keyword>rosiglitazone</keyword>
	<keyword>Amylin</keyword>
	<keyword>Lilly</keyword>
</DOC>